New Application of Viable PCR for Following Early Tuberculosis Treatment
Italian researchers from San Raffaele Scientific Institute,(Milan) report an innovative approach to selectively amplify DNA derived from viable Mycobacterium tuberculosis in clinical specimens, which is useful for monitoring mycobacterial load in pulmonary TB patients during anti-TB treatment.
The procedure is based in a sample pre treatment with PMA (500uM, 30 min a 4ºC in the dark ) and 15 min of photo activation with a Geniul system. Please click here for further information.
Tags: Mycobacterium, PCR, Mycobacterium tuberculosis
Date Published: May 21, 2012
Source article link: GENIUL, S.L. » company contact details
GC and CFU Correlation Of 9 Mycoplasma spp Examined With Sartorius' Microsart® Range
Why Bio-Rad? Learn More Here!
GNA Biosolutions Revealed New Ultrafast PCR Platform
iQ-Check® Free DNA Removal Solution for Legionella
Bio-Rad's Salmonella PCR Kit Receives AOAC OMA Approval